Multidrug-resistant Streptococcus pneumoniae.
Antimicrobial resistance in pneumococci is well established. Of major concern is the development of resistance to penicillin; however, reduced susceptibility to other commonly used agents such as chloramphenicol, erythromycin, and tetracycline has also been observed with increasing frequency. We wish to report the isolation of a clinical strain of Streptococcus pneumoniae with intermediate susceptibility to penicillin (minimum inhibitory concentration, 1 mg/L), which was also resistant to numerous other antimicrobial agents.
Catchpole
C
C
Department of Microbiology, City Hospital Trust, Birmingham, United Kingdom.
Fraise
A
A
Wise
R
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications; D011008:Pneumococcal Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000235:genetics
D000900:Anti-Bacterial Agents